ClinicalTrials.Veeva

Menu

HEMOVAR Study on Hemorrhoids and Varicose Veins

A

Aydin Adnan Menderes University

Status

Enrolling

Conditions

Varicose Veins of Lower Limb
Hemorrhoids

Study type

Observational

Funder types

Other

Identifiers

NCT07317492
2025/299-24 (Other Identifier)
HEMOVAR-ADU-2025-01

Details and patient eligibility

About

The HEMOVAR Study is a prospective observational study designed to evaluate the association between hemorrhoidal disease and lower extremity varicose veins. A total of 400 adult patients presenting to the general surgery proctology outpatient clinic of Aydın Adnan Menderes University Hospital will be included. The study will consist of two groups: 200 patients diagnosed with hemorrhoids and 200 patients with other non-hemorrhoidal benign proctologic conditions serving as controls.

All participants will undergo routine clinical evaluation and demographic data collection. Cardiovascular surgeons will voluntarily perform physical examination and Doppler ultrasonography of the lower extremities to assess venous insufficiency and varicose veins. No experimental intervention or treatment will be applied. The study will not require any consumable materials and will not impose any additional financial burden on the hospital, patients, or the national health insurance system. The primary outcome is the prevalence of lower extremity venous insufficiency in patients with hemorrhoids compared with controls.

Full description

The HEMOVAR Study is a single-center, prospective, cross-sectional observational investigation conducted at Aydın Adnan Menderes University Hospital. The study aims to examine the association between hemorrhoidal disease and lower extremity venous insufficiency using standardized clinical assessment and Doppler ultrasonography. Adult patients presenting to the general surgery proctology outpatient clinic will be screened for eligibility and enrolled after providing written informed consent.

Two parallel groups will be formed: patients with clinically diagnosed hemorrhoids and a control group consisting of patients with other benign non-hemorrhoidal proctologic conditions. Cardiovascular surgeons will voluntarily perform clinical examination and color Doppler ultrasonography of the lower limb venous system in all participants. Doppler parameters including the presence of venous reflux, affected venous segments, reflux duration, venous diameter, and CEAP clinical classification will be recorded. Laboratory evaluation will be limited to hemoglobin measurement. Secondary analyses will explore the coexistence of other venous disorders such as varicocele and pelvic congestion syndrome.

This study involves no experimental intervention, randomization, or invasive procedures. No consumables will be used, and there will be no additional financial burden on the hospital, patients, or the national health insurance system. The study will commence following approval by the local ethics committee, and data will be collected and analyzed in accordance with the Declaration of Helsinki and Good Clinical Practice principles.

Enrollment

400 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults aged 18 years or older
  • Patients presenting to the general surgery proctology outpatient clinic of Aydın Adnan Menderes University Hospital
  • Patients diagnosed with hemorrhoidal disease or other non-hemorrhoidal benign proctologic conditions
  • Ability to understand the study procedures and provide written informed consent

Exclusion criteria

  • Patients younger than 18 years
  • History of lower extremity varicose vein surgery, endovenous ablation, or sclerotherapy
  • Presence of systemic venous disorders such as portal hypertension or liver cirrhosis
  • Pregnant women
  • Patients with known malignancy or severe comorbid conditions that could interfere with evaluation
  • Refusal or inability to provide written informed consent

Trial design

400 participants in 2 patient groups

Hemorrhoid Group
Description:
Adult patients (≥18 years) diagnosed with hemorrhoidal disease presenting to the general surgery proctology clinic.
Control Group
Description:
Adult patients (≥18 years) with non-hemorrhoidal benign proctologic diseases presenting to the same clinic.

Trial contacts and locations

1

Loading...

Central trial contact

Akay Edizsoy, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems